Provided by Tiger Trade Technology Pte. Ltd.

MEI Pharma

3.07
0.0000
Volume:- -
Turnover:12.12M
Market Cap:100.81M
PE:-0.65
High:3.07
Open:3.07
Low:3.07
Close:3.07
52wk High:9.00
52wk Low:1.46
Shares:32.84M
Float Shares:31.66M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7521
EPS(LYR):2.67
ROE:-89.74%
ROA:-23.23%
PB:5.16
PE(LYR):1.15

Loading ...

Dec 17, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 09, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jul 02, 2020

Major Issues Report

8-K - Current report
May 14, 2020

Correspondence

CORRESP [Cover] - Correspondence
May 07, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 14, 2020

Major Issues Report

8-K - Current report
Apr 14, 2020

Major Issues Report

8-K - Current report
Mar 20, 2020

Major Issues Report

Current report, items 5.03 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 06, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Feb 05, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Dec 30, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Dec 18, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Dec 06, 2019

[Rev.]Annual Report

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 06, 2019

Major Issues Report

Current report, item 5.07